» Articles » PMID: 31605462

Organ Sparing of Linac-based Targeted Marrow Irradiation over Total Body Irradiation

Overview
Date 2019 Oct 13
PMID 31605462
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Targeted marrow irradiation (TMI) is an alternative conditioning regimen to total body irradiation (TBI) before bone marrow transplantation in hematologic malignancies. Intensity-modulation methods of external beam radiation therapy are intended to permit significant organ sparing while maintaining adequate target coverage, improving the therapeutic ratio. This study directly compares the dose distributions to targets and organs at risk from TMI and TBI, both modalities conducted by general-use medical linacs at our institution.

Methods: TMI treatments were planned for 10 patients using multi-isocentric feathered volumetric arc therapy (VMAT) plans, delivered by 6 MV photon beams of Elekta Synergy linacs. The computed tomography (CT) datasets used to obtain these plans were also used to generate dose distributions of TBI treatments given in the AP/PA extended-field method. We compared dose distributions normalized to the same prescription for both plan types. The generalized equivalent uniform dose (gEUD) of Niemierko for organs and target volumes was used to quantify effective whole structure dose and dose savings.

Results: For the clinical target volume (CTV), no significant differences were found in mean dose or gEUD, although the radical dose homogeneity index (minimum dose divided by maximum dose) was 31.7% lower (P = 0.002) and the standard deviation of dose was 28.0% greater (P = 0.027) in the TMI plans than in the TBI plans. For the TMI plans, gEUD to the lungs, brain, kidneys, and liver was significantly lower (P < 0.001) by 47.8%, 33.3%, 55.4%, and 51.0%, respectively.

Conclusion: TMI is capable of maintaining CTV coverage as compared to that achieved in TBI, while significantly sparing organs at risk. Improvement on sparing organs at risk permits a higher prescribed dose to the target or the maximum number of times marrow conditioning may be delivered to a patient while maintaining similar typical tissue complication rates.

Citing Articles

Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation.

Dei D, Lambri N, Stefanini S, Vernier V, Brioso R, Crespi L Cancers (Basel). 2023; 15(5).

PMID: 36900326 PMC: 10000500. DOI: 10.3390/cancers15051536.


Commissioning of a three-dimensional arc-based technique for total body irradiation.

Aldrovandi L, Farias R, Mauri M, Mairal M J Appl Clin Med Phys. 2021; 22(9):123-142.

PMID: 34258860 PMC: 8425872. DOI: 10.1002/acm2.13355.


[Containing total marrow irradiation conditioning regimen for patients with leukemia undergoing hematopoietic stem cell transplantation].

Zhao X, Wang H Zhonghua Xue Ye Xue Za Zhi. 2020; 41(6):525-528.

PMID: 32654472 PMC: 7378288. DOI: 10.3760/cma.j.issn.0253-2727.2020.06.019.

References
1.
Boucek J, Turner J . Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in (131)I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging. 2005; 32(4):458-69. DOI: 10.1007/s00259-004-1692-9. View

2.
Alyea E, Neuberg D, Mauch P, Marcus K, FREEDMAN A, Webb I . Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2002; 8(3):139-44. DOI: 10.1053/bbmt.2002.v8.pm11939603. View

3.
Burman C, Kutcher G, Emami B, Goitein M . Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991; 21(1):123-35. DOI: 10.1016/0360-3016(91)90172-z. View

4.
Wilkie J, Tiryaki H, Smith B, Roeske J, Radosevich J, Aydogan B . Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys. 2009; 35(12):5609-18. DOI: 10.1118/1.2990779. View

5.
Son J, Choi N, Kim J, Park J, Wu H, Kang H . Effect of changes in monitor unit rate and energy on dose rate of total marrow irradiation based on Linac volumetric arc therapy. Radiat Oncol. 2019; 14(1):87. PMC: 6537431. DOI: 10.1186/s13014-019-1296-y. View